Key Decisions in HIV Care: Data on Long-Acting Injectable PrEP

Listen as Jason Schafer, PharmD, MPH, shares the latest data to support long-acting PrEP, including efficacy and safety data from the major clinical trials that led to the approval of cabotegravir for PrEP.